Trend-Following Backtester · Guide · backtest 한국어

equity · CH

BB Biotech AG backtest

10 trend-following strategies were compared on the full daily history of BB Biotech AG. 5 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is MACD (CAGR 4.2%, MDD -41.1%).

Data 2000-01-04 ~ 2026-07-31daily bars 6,744 (26.6 years)Costs 0.5%Venue SIXMonthly snapshot 2026-07-31

Results by strategy

5 of 10 beat buy and hold (CAGR 3.4%, drawdown -82.0%).

Sharpe leader (same as main): Supertrend — CAGR 5.6%, MDD -47.0%, Sharpe 0.38, 52% exposure.

Return/drawdown alternative: MACD — CAGR is 2.2%p higher than buy and hold, while drawdown improves by 35.0%p (CAGR 4.2%, MDD -41.1%, exposure 51%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=13, mult=3.8
5.6%-47.0%0.380.124.2x14352%
EMA 크로스오버
fast=15, slow=207
4.3%-48.4%0.330.093.1x5152%
Donchian 채널 돌파
entryN=11, exitN=40
5.0%-64.4%0.320.083.6x11177%
MACD
fast=21, slow=57, signal=23
4.2%-41.1%0.310.102.9x22151%
SMA 크로스오버
fast=34, slow=209
3.7%-54.8%0.300.072.7x3953%
ROC 모멘텀
n=210, threshold=0.07
2.3%-52.0%0.220.041.8x16543%
볼린저 밴드 돌파
n=56, k=1.6
1.4%-54.3%0.170.031.5x12938%
Parabolic SAR
step=0.005, maxStep=0.28
0.6%-74.0%0.130.011.2x22153%
Keltner 채널 돌파
emaPeriod=56, atrPeriod=24, mult=1.7
0.7%-64.6%0.120.011.2x16341%
ADX / DI 방향성
period=13, threshold=17
-2.5%-76.1%-0.08-0.030.5x44138%
Buy and hold3.4%-82.0%0.260.042.4x1100%
1x 2001 2005 2009 2013 2017 2021 2025 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -21% -41% -62% -82% 2001 2005 2009 2013 2017 2021 2025 Buy and holdSupertrend
Supertrend maximum drawdown -47.0% (2021-02-09 → 2025-05-14), prior peak not yet recovered.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next